annual CFO:
-$230.11M-$84.74M(-58.29%)Summary
- As of today (June 28, 2025), AKRO annual cash flow from operations is -$230.11 million, with the most recent change of -$84.74 million (-58.29%) on December 31, 2024.
- During the last 3 years, AKRO annual CFO has fallen by -$150.43 million (-188.79%).
- AKRO annual CFO is now -4875.29% below its all-time high of -$4.63 million, reached on December 31, 2018.
Performance
AKRO Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$67.66M-$574.00K(-0.86%)Summary
- As of today (June 28, 2025), AKRO quarterly cash flow from operations is -$67.66 million, with the most recent change of -$574.00 thousand (-0.86%) on March 31, 2025.
- Over the past year, AKRO quarterly CFO has dropped by -$32.52 million (-92.56%).
- AKRO quarterly CFO is now -26857.77% below its all-time high of -$251.00 thousand, reached on June 30, 2018.
Performance
AKRO quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$262.63M-$32.52M(-14.13%)Summary
- As of today (June 28, 2025), AKRO TTM cash flow from operations is -$262.63 million, with the most recent change of -$32.52 million (-14.13%) on March 31, 2025.
- Over the past year, AKRO TTM CFO has dropped by -$106.76 million (-68.49%).
- AKRO TTM CFO is now -77601.48% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AKRO Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.3% | -92.6% | -68.5% |
| 3 y3 years | -188.8% | -195.8% | -211.9% |
| 5 y5 years | -545.9% | -497.9% | -532.9% |
AKRO Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -188.8% | at low | -246.8% | +3.9% | -213.8% | at low |
| 5 y | 5-year | -545.9% | at low | -497.9% | +3.9% | -532.9% | at low |
| alltime | all time | -4875.3% | at low | <-9999.0% | +3.9% | <-9999.0% | at low |
AKRO Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$67.66M(+0.9%) | -$262.63M(+14.1%) |
| Dec 2024 | -$230.11M(+58.3%) | -$67.09M(-4.7%) | -$230.11M(+8.7%) |
| Sep 2024 | - | -$70.42M(+22.6%) | -$211.64M(+10.8%) |
| Jun 2024 | - | -$57.45M(+63.5%) | -$190.94M(+22.5%) |
| Mar 2024 | - | -$35.14M(-27.7%) | -$155.88M(+7.2%) |
| Dec 2023 | -$145.37M(+57.1%) | -$48.63M(-2.2%) | -$145.37M(+18.9%) |
| Sep 2023 | - | -$49.72M(+122.1%) | -$122.25M(+25.8%) |
| Jun 2023 | - | -$22.39M(-9.1%) | -$97.15M(+3.1%) |
| Mar 2023 | - | -$24.63M(-3.4%) | -$94.27M(+1.9%) |
| Dec 2022 | -$92.52M(+16.1%) | -$25.51M(+3.6%) | -$92.52M(-1.3%) |
| Sep 2022 | - | -$24.62M(+26.2%) | -$93.70M(+12.0%) |
| Jun 2022 | - | -$19.51M(-14.7%) | -$83.69M(-0.6%) |
| Mar 2022 | - | -$22.88M(-14.3%) | -$84.21M(+5.7%) |
| Dec 2021 | -$79.68M | -$26.70M(+82.8%) | -$79.68M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$14.61M(-27.1%) | -$76.38M(+1.5%) |
| Jun 2021 | - | -$20.03M(+9.2%) | -$75.28M(-3.3%) |
| Mar 2021 | - | -$18.35M(-21.6%) | -$77.83M(+9.9%) |
| Dec 2020 | -$70.80M(+98.7%) | -$23.39M(+73.2%) | -$70.80M(+19.9%) |
| Sep 2020 | - | -$13.51M(-40.2%) | -$59.06M(+0.5%) |
| Jun 2020 | - | -$22.58M(+99.6%) | -$58.76M(+41.6%) |
| Mar 2020 | - | -$11.32M(-2.9%) | -$41.50M(+16.5%) |
| Dec 2019 | -$35.63M(+670.3%) | -$11.65M(-11.8%) | -$35.63M(+36.7%) |
| Sep 2019 | - | -$13.21M(+148.3%) | -$26.05M(+76.0%) |
| Jun 2019 | - | -$5.32M(-2.2%) | -$14.80M(+52.1%) |
| Mar 2019 | - | -$5.44M(+162.4%) | -$9.73M(+110.4%) |
| Dec 2018 | -$4.63M | -$2.08M(+5.8%) | -$4.63M(+81.4%) |
| Sep 2018 | - | -$1.96M(+681.3%) | -$2.55M(+332.9%) |
| Jun 2018 | - | -$251.00K(-25.7%) | -$589.00K(+74.3%) |
| Mar 2018 | - | -$338.00K | -$338.00K |
FAQ
- What is Akero Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Akero Therapeutics?
- What is Akero Therapeutics annual CFO year-on-year change?
- What is Akero Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Akero Therapeutics?
- What is Akero Therapeutics quarterly CFO year-on-year change?
- What is Akero Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Akero Therapeutics?
- What is Akero Therapeutics TTM CFO year-on-year change?
What is Akero Therapeutics annual cash flow from operations?
The current annual CFO of AKRO is -$230.11M
What is the all time high annual CFO for Akero Therapeutics?
Akero Therapeutics all-time high annual cash flow from operations is -$4.63M
What is Akero Therapeutics annual CFO year-on-year change?
Over the past year, AKRO annual cash flow from operations has changed by -$84.74M (-58.29%)
What is Akero Therapeutics quarterly cash flow from operations?
The current quarterly CFO of AKRO is -$67.66M
What is the all time high quarterly CFO for Akero Therapeutics?
Akero Therapeutics all-time high quarterly cash flow from operations is -$251.00K
What is Akero Therapeutics quarterly CFO year-on-year change?
Over the past year, AKRO quarterly cash flow from operations has changed by -$32.52M (-92.56%)
What is Akero Therapeutics TTM cash flow from operations?
The current TTM CFO of AKRO is -$262.63M
What is the all time high TTM CFO for Akero Therapeutics?
Akero Therapeutics all-time high TTM cash flow from operations is -$338.00K
What is Akero Therapeutics TTM CFO year-on-year change?
Over the past year, AKRO TTM cash flow from operations has changed by -$106.76M (-68.49%)